KLOW is a research peptide blend formulated to combine four investigational peptides into a single laboratory-grade product:
- GHK-Cu (Copper Tripeptide-1)
- BPC-157
- TB-500
- KPV
Each component has been individually investigated for its role in tissue biology, extracellular matrix remodeling, inflammatory signaling, and cellular repair pathways. The KLOW blend was developed to provide researchers with a convenient formulation for studying multiple biological pathways simultaneously in laboratory settings.
Researchers are investigating the individual components of the KLOW blend in areas including:
- Tissue repair and regeneration
- Cellular migration and remodeling
- Collagen and extracellular matrix biology
- Inflammatory signaling pathways
- Angiogenesis and vascular biology
- Skin and connective tissue research
- Gastrointestinal and musculoskeletal research models
While each peptide has an independent body of preclinical research, the combined KLOW formulation has not been evaluated in controlled clinical studies, and any interactions between the components remain an area for future investigation.